|
|
||
|---|---|---|
| UniProt ID |
P17948 |
|
| Entry Name |
VGFR1_HUMAN |
|
| Protein Name |
Vascular endothelial growth factor receptor 1 |
|
| Primary Gene Name |
FLT1 |
|
| Organism |
Homo sapiens (Human) |
|
| Molecular Function |
Tyrosine-protein kinase |
|
| Membrane Location |
Secreted |
|
|
|
|---|
| Substrate Name | VEGFR-1/FLT1 | |
| Cell Type | ||
| Substrate Description | Tyrosine-protein kinase, cell-surface receptor for VEGFA, VEGFB and PGF | |
| Substrate Function Category | angiogenesis | |
| Substrate Function Subtype | ||
| Sheddase | ADAM | |
| Shedding-related Disease | cell receptor | |
| Short Summary of Papers | VEGFR-1 undergo cleavage by ADAM and γ-secretase (regulated intramembrane proteolysis) sequentially, the shed sVEGFR-1 may antagonize VEGF receptor signaling by acting as a dominant-negative form and/or forming a nonsignaling dimerizing complex with VEGF receptors. | |
| Cleavage Information | NONE | |
| PMID | 19276374 |
|
|
|---|
|
|
||
|---|---|---|
|
|
Start | End |
|
|
27 | 758 |
|
|
759 | 780 |
|
|
||||||||
|---|---|---|---|---|---|---|---|---|
| Database | CutSeq | Mapped Position | Protease | Type | Evidence | PMID | ||
| PAPER | No_information | ADAM | 19276374    | |||||
|
|
|||
|---|---|---|---|
| Secretome Database | Cell Type or Body Fluid | PubMed Reference | |
| SPD | 22728825 | ||
| Sys-BodyFluid | Plasma/Serum | 16104056 | |
| Sys-BodyFluid | Amniotic fluid | 17495049 | |
| Sys-BodyFluid | Plasma/Serum | 16878292 | |
| Sys-BodyFluid | Plasma/Serum | 17553692 | |
| Sys-BodyFluid | Plasma/Serum | 14718574 | |
| HCSD | cancer(23 cancer cell lines) | 20124221 | |
| HCSD | cancer(Liver metastasis in colorectal cancer) | 23443137 | |